📰 Clinical Research Program News
Page 2 - Clinical Research Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Research Program. Real-time updates on events, politics, business and more.
February 23, 2024
Priority Review granted based on positive results from two Phase 3 trials; if approved, Dupixent would be the only biologic therapy for COPD and the first new treatment approach for this disease in more than a decade Regulatory submissions are also under review in China and Europe Dupixent is the leading biologic treatment for all five of its FDA-approved indications in new-to-brand prescriptions in the U.S. TARRYTOWN, N.Y. and PARIS, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals,
February 23, 2024
Priority Review granted based on positive results from two Phase 3 trials; if approved, Dupixent would be the only biologic therapy for COPD and the first new treatment approach for
February 23, 2024
Priority Review granted based on positive results from two Phase 3 trials; if approved, Dupixent would be the only biologic therapy for COPD and the first new treatment approach for this disease in...
February 14, 2024
High-risk pregnancy specialists from the Mount Sinai Health System are presenting research at the Annual Pregnancy Meeting of the Society for Maternal-Fetal Med
February 14, 2024
High-risk pregnancy specialists from the Mount Sinai Health System are presenting research at the Annual Pregnancy Meeting of the Society for Maternal-Fetal Med
February 7, 2024
The University of Hawaii Cancer Center hopes to address treatment needs through its planned Early Phase Clinical Research Center.
January 12, 2024
(KNSI) - St. Cloud State University announced two initiatives that will help it reach more students in the Twi...
December 12, 2023
This Week in Washington: House Energy and Commerce Committee markup includes 19 healthcare bills; Senate HELP Committee to mark up SUPPORT Act Reauthorization and three other bills;...
November 27, 2023
NOTUS trial met its primary endpoint with overwhelming efficacy, showing Dupixent significantly reduced exacerbations by 34% compared to placebo in patients with moderate-to-severe COPD with evidence...
November 25, 2023
Research with animal models suggests that trans-vaccenic acid has the potential to optimize the impact of immunotherapy in oncology. Experts, however, recommend caution